About BioQual
BioQual is a company based in Rockville (United States) founded in 1981 by John Landon. BioQual has completed 1 acquisition, including ABL. BioQual offers products and services including In Vitro Services, Animal Models, and Research Solutions. BioQual operates in a competitive market with competitors including Gentronix, Jade Bioscience, Tigermed, Shanghai Yaocheng Health Technology and ReveraGen, among others.
- Headquarter Rockville, United States
- Founders John Landon
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioqual, Inc.
-
Annual Revenue
$48.87 M (USD)-16.6as on May 31, 2024
-
Net Profit
-$1.05 M (USD)-316.79as on May 31, 2024
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioQual
BioQual is a publicly listed company on the OTC with ticker symbol BIOQ in USA, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioQual
BioQual offers a comprehensive portfolio of products and services, including In Vitro Services, Animal Models, and Research Solutions.
Offers cell-based assays and immunoassays for research support.
Provides small and large animals for preclinical disease studies.
Delivers tailored toxicology and assay development for clients.
People of BioQual
Unlock access to complete
Funding Insights of BioQual
Detailed funding history for BioQual
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioQual
BioQual has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ABL.
Investment portfolio details for BioQual
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contract research and manufacturing for biologics and vaccines are provided.
|
Locked | Locked | 1961 | Locked |
Complete acquisition details for BioQual
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BioQual
Detailed financials for BioQual
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioqual Comparisons
Peer comparison for BioQual
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioQual
BioQual operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Jade Bioscience, Tigermed, Shanghai Yaocheng Health Technology and ReveraGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Provides toxicology, chemistry, and consultancy services for agrochemical industries.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Clinical trial services to biopharma sector are provided.
|
|
| Locked | Locked | Locked |
Steroids for Duchenne muscular dystrophy treatment are developed.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Detailed competitors of BioQual
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioqual
Complete news archive for BioQual
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioQual
BioQual was founded in 1981.
BioQual is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Annual revenue of BioQual is $48.87M as on May 31, 2024.
BioQual was founded in 1981 and is based in Rockville, United States, operating as a contract research organization in the biotechnology sector. Services are provided for in vivo models of human diseases such as AIDS, influenza, RSV, Zika, dengue, malaria, hepatitis, and cancer. Evaluations of vaccines, therapeutics, microbicides, and drug therapies are performed, alongside in vitro assessments of immunologic, virologic, and molecular parameters including sample processing and virus neutralization assays.
BioQual's top competitors include PHAXIAM, Jade Bioscience and Tigermed.
BioQual offers In Vitro Services, Animal Models, and Research Solutions.
Yes, BioQual is publicly traded on OTC under the ticker symbol BIOQ.
BioQual has made 1 acquisition, including ABL.
The ticker symbol of BioQual is BIOQ on OTC.